Smith and Nephew Wound Management (La Jolla) Dermagraft, Human Fibroblast -Derived Dermal Substitute, 2 in. by 3 in.. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Dermagraft, Human Fibroblast -Derived Dermal Substitute, 2 in. by 3 in..
Brand
Smith and Nephew Wound Management (La Jolla)
Lot Codes / Batch Numbers
Lot 116098
Products Sold
Lot 116098
Smith and Nephew Wound Management (La Jolla) is recalling Dermagraft, Human Fibroblast -Derived Dermal Substitute, 2 in. by 3 in.. due to Did not meet finished device specifications for the DNA criteria.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Did not meet finished device specifications for the DNA criteria.
Recommended Action
Per FDA guidance
Recall was by telephone on or about May 2, 2003 and by letter on May 7, 2003. Product is to be returned.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026